Search

Becton Dickinson and Company has been issued a patent for radio frequency identification (RFID) inlays for use with medical injection devices. The patent describes a tip cap assembly for coupling with a syringe body, which includes a RFID tag positioned over the distal end of the rigid tip cap. The RFID tag is resistant to damage and tampering, provides evidence in the event of tampering, and improves machine readability. The patent also mentions different embodiments of the RFID tag, such as circular RFID inlays, and different adhesive layers that can be used. This technology aims to provide individual traceability of medical containers and improve the tracking of medical devices from manufacturing to disposal. [Extracted from the article]

A patent application titled "Authorizing Programming Of An Implanted Device Using Second Factor" has been published online by the US Patent and Trademark Office. The patent application, filed by inventors Adam Bildersee, Michael Andrew Caruso, Arvind Govindaraj, Nehal Patel, and James Salvia, and assigned to Verily Life Sciences LLC, addresses the lack of security during pairing for a communication connection between an implantable medical device (IMD) and an external device. The system described in the patent application ensures secure pairing by enabling a window of exclusivity for the external device, transmitting an authorization instruction message to the external device, and receiving an authorization pulse from an authorization device. The method involves using wireless communication paths and may include features such as short-wavelength ultra-high frequency radio waves, inductive communication paths, and near-field communication paths. [Extracted from the article]

A patent application by inventor Scott D. Augustine describes a system for counting and detecting surgical sponges using radio frequency identification (RFID) technology. The application proposes using two different RFID systems in parallel to improve reliability. One system would use a sophisticated and expensive UHF-RFID identifier for counting outside the body, while the other would use a cheaper EAS identifier for detection within the body. By combining these two technologies, the failure rate of the system could be significantly reduced. The application also discusses various design considerations for the RFID tags and sponges to optimize their performance. [Extracted from the article]

A study conducted by researchers at Ahvaz Jundishapur University of Medical Sciences in Iran found that cell phone and ultra-high frequency (UHF) waves can cause oxidative stress and testicular toxicity in rats. The researchers investigated the effectiveness of Rosmarinic Acid (RA) in protecting against this damage. The study involved 42 male Wistar rats divided into different groups, and after 30 days of radiation exposure, the researchers measured the biochemical and histopathological parameters of their testes. The results showed that UHF radiation significantly reduced antioxidant enzyme activity and increased oxidative stress indices, while RA reversed these effects and improved histological parameters. The researchers concluded that RA could potentially be used as a food supplement to protect humans from UHF-induced toxicity. [Extracted from the article]

A patent application titled "Ultra-High Frequency At-Cut Quartz Blank And Manufacturing Method Thereof" has been published online. The inventors discuss the need for miniaturization and high frequency in quartz crystal resonators due to the increasing demand for mobile communication technology and the promotion of 5G. They propose an ultra-high frequency AT-cut quartz blank and a manufacturing method to solve the problem of quartz blank fragmentation caused by the mass loading effect. The patent application provides detailed information on the structure and manufacturing process of the quartz blank. [Extracted from the article]

A recent report from the University of Electronic Science and Technology of China discusses the findings of a study on Mn-substituted Co2z ferrite ceramics for ultra-high frequency miniaturization antennas. The researchers prepared a series of ceramics with varying levels of Mn substitution and found that the samples with x = 0.1-0.2 exhibited the best microwave properties and had high miniaturization factors. The study concludes that these ceramics have great potential for use in ultra-high frequency miniaturized antenna substrates. The research was funded by various organizations in China and has been peer-reviewed. [Extracted from the article]

A patent has been issued to Verily Life Sciences LLC for a system and method to ensure secure pairing between an external device and an implantable medical device (IMD). The IMD receives a pairing request from the external device and enables a window of exclusivity, preventing other devices from pairing. The IMD then transmits an authorization instruction message to the external device and receives an authorization pulse from an authorization device. Upon receiving the pulse, the pairing is finalized. The method includes various features such as canceling broadcast messages, securing communication with encryption, and using inductive or near-field communication paths. [Extracted from the article]

A recent report from the University of Helsinki and Helsinki University Hospital provides new insights into heart failure in pediatric Mulibrey nanism (MUL). The study used ultra-high frequency ultrasound to assess arterial and venous morphology, arterial stiffness, and other cardiovascular parameters in a group of MUL patients. The researchers found that arterial lumen diameters and wall layer thickness were smaller in MUL patients compared to healthy controls, but were appropriate for body size. Venous wall thickness was elevated in MUL patients, potentially due to increased venous pressures related to diastolic heart failure. Overall, the study suggests that vascular structure and stiffness in MUL patients are similar to healthy controls, with some mild venous remodeling. [Extracted from the article]

Keywords: Atopic Dermatitis; Dermatitis; Dermatology; Drugs and Therapies; Dupilumab Therapy; Electronics; Health and Medicine; Immunologic Agents; Immunotherapy; Monoclonal Antibodies; Pharmaceuticals; Skin Diseases and Conditions; Skin and Connective Tissue Diseases and Conditions; Ultra High Frequency EN Atopic Dermatitis Dermatitis Dermatology Drugs and Therapies Dupilumab Therapy Electronics Health and Medicine Immunologic Agents Immunotherapy Monoclonal Antibodies Pharmaceuticals Skin Diseases and Conditions Skin and Connective Tissue Diseases and Conditions Ultra High Frequency 1412 1412 1 09/25/23 20230925 NES 230925 2023 SEP 29 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Researchers detail new data in atopic dermatitis. According to news originating from Pisa, Italy, by NewsRx editors, the research stated, "Atopic dermatitis (AD) is a chronic multifactorial inflammatory disease characterized by intense itching and inflammatory eczematous lesions. We enrolled 18 patients with moderate-to-severe AD, divided into two groups: twelve patients in the dupilumab treatment (Group A) and six patients in standard treatment, from February 2019 to November 2019. [Extracted from the article]

Keywords: Pisa; Italy; Europe; Bariatrics; Diet and Nutrition; Electronics; Health and Medicine; Morbid Obesity; Nutrition Disorders; Nutritional and Metabolic Diseases and Conditions; Obesity; Obesity and Diabetes; Overnutrition; Ultra High Frequency EN Pisa Italy Europe Bariatrics Diet and Nutrition Electronics Health and Medicine Morbid Obesity Nutrition Disorders Nutritional and Metabolic Diseases and Conditions Obesity Obesity and Diabetes Overnutrition Ultra High Frequency 192 192 1 07/31/23 20230731 NES 230731 2023 JUL 31 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Nutritional and Metabolic Diseases and Conditions - Morbid Obesity have been published. As regard the parameters of vascular elasticity, the DC of radial and interdigital arteries were lower (p = 0.025 and p = 0.001, respectively), as well as the Einc of radial arteries was higher (p = 0.021), in subject with obesity compared to controls. [Extracted from the article]

Keywords: Business; Diathermy; Electronics; Health and Medicine; Induced Hyperthermia; Swiss Reju; Technology; Ultra High Frequency EN Business Diathermy Electronics Health and Medicine Induced Hyperthermia Swiss Reju Technology Ultra High Frequency 2604 2604 1 04/10/23 20230414 NES 230414 2023 APR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- SWISS REJU, an awarding-winning luxury beauty advisory located in Central, Hong Kong, is thrilled to announce the launching of a new generation of non-invasive slimming energy modality, "2.45GHz diathermy technology". Business, Diathermy, Electronics, Health and Medicine, Induced Hyperthermia, Swiss Reju, Technology, Ultra High Frequency. [Extracted from the article]

Keywords: Shanghai; People's Republic of China; Asia; Basal Cell Cancer; Basal Cell Carcinoma; Bowen's Disease; Cancer; Carcinomas; Dermatology; Diagnostics and Screening; Electronics; Health and Medicine; Oncology; Squamous Cell Carcinoma; Ultra High Frequency EN Shanghai People's Republic of China Asia Basal Cell Cancer Basal Cell Carcinoma Bowen's Disease Cancer Carcinomas Dermatology Diagnostics and Screening Electronics Health and Medicine Oncology Squamous Cell Carcinoma Ultra High Frequency 772 772 1 03/23/23 20230314 NES 230314 2023 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Oncology - Basal Cell Cancer have been presented. According to the news editors, the research concluded: "UHFUS provides detailed internal features of sBCC and BD, which facilitates the differentiation between sBCC and BD and its diagnostic performance is superior to clinical diagnosis.". [Extracted from the article]